Image of MPN Heroes Image of MPN Heroes Image of MPN Heroes

Honor the MPN Heroes in Your Life!

MPN Heroes logo

Since 2013, the MPN Heroes Recognition Program has recognized the people and organizations that have dedicated themselves to improving the lives of people with myeloproliferative neoplasms, or MPNs. The program focuses on the three "classical" MPNs—or what are known as Philadelphia chromosome–negative MPNs.

Created in the spirit of fostering community, the program recognizes patients, Healthcare Professionals, caregivers, advocates, and organizations that contribute to bringing understanding, compassion, and strength to the MPN community.

2022 marks the tenth anniversary of the MPN Heroes Recognition Program, sponsored by Incyte Corporation and CURE magazine. Our goal is to create as many opportunities as possible for people with MPNs to be heard and to be supported, so more solutions and treatment options will emerge.

Who Is an MPN Hero?

Thank you to all who participated in the 2021 MPN Heroes Recognition Program by nominating someone who has made a difference in MPN care. Your hero may be any of the following:

  • Patient whose strength has inspired you
  • Caregiver who has consistently offered you support and reassurance
  • Healthcare Professional who has listened to you and treated you with compassion
  • Organization or institution dedicated to improving MPN care and support

When Is the MPN Heroes Celebration Event?

The 2021 MPN Heroes Celebration Event, hosted by CURE Media Group, will be held in December.

Who Are the Sponsors of the MPN Heroes® Recognition Program?

MPN Heroes is a program sponsored by Incyte Corporation and CURE magazine.

Incyte logo
Cure logo

What Are the Rules for the 2021 MPN Heroes Recognition Program?

The MPN Heroes program recognizes dedication to individuals and the MPN community. Individuals or organizations were nominated in one of two categories. Recipients were selected by a judging panel's review of nominations for recognition. Members of the judging panel received honoraria for their service. In Category A, up to four recognition plaques were given to chosen recipients, and in Category B, up to four monetary donations to non-profit organizations and societies were given in recognition of the four recipients recognized in this category. Incyte made monetary donations to select non-profit 501(c)(3), US-based organizations or societies that improve the lives of individuals with MPNs.

Criteria for nominations in either category are as follows:

  • Choose only one category for the nominee to be considered
  • Clearly state the MPN (MF, PV, or ET) patient need being addressed
  • A completed nomination form must be submitted by September 9, 2021
  • The achievements of the organization or individual must be recent (ie, should have taken place within the last 24 months)
  • Organizations may submit an entry for their own program, but it must be for one specific activity or program and only one entry per year, and we strongly encourage independent confirmation
  • Individuals can be recognized posthumously
  • Institutions, organizations, or individuals can be nominated by themselves or by others, but they must be aware of the nomination, and the nomination must be approved by, and compliant with, any institutional rules and guidelines

Criteria: Category A: Commitment to the individual. Recognizing individuals who provide or demonstrate care, guidance, education, or support above and beyond the standard of care for one or more patients with MPNs. Types of work honored include demonstration of individual dedication by a nurse, Healthcare Professional, or caregiver whose contributions to an individual with an MPN had an evident impact.

Criteria: Category B: Commitment to the broader MPN community. Recognizing leadership in developing services or programs addressing the needs of patients with MPNs, families, friends, caregivers, and medical professionals through advancing the science and medical understanding of MPNs, education, awareness, or approaches to care.

Types of work honored could include advocating for better care, outreach to underserved populations, activities at the grassroots level, promoting the patient’s voice, providing MPN community leadership, creating awareness programs, innovative education materials, programs, or events, disease management initiatives, research and science-based programs, media outreach, or campaigns.


  • Employees or agents of Incyte, VOZ Advisors, or other Incyte vendors and members of their immediate family as well as current program year judging panel members are not eligible for recognition
  • Nominated individuals, institutions, or organizations and the programs or activities nominated must originate and be executed in one or more of the 50 states of the United States, the District of Columbia, or Puerto Rico
  • Nominated programs must be independent of purchase, use, and prescribing for any Incyte product
  • The following are ineligible for recognition:
    • Programs or activities that Incyte provided grants or other funding for directly
    • Political lobbying activities
    • Medical research or publications that have been funded or directed by Incyte
    • Any nominee whose organization or institution does not allow recognition in the manner set forth in this program
  • Nominated individuals or organizations must serve or be involved with the myelofibrosis (MF), polycythemia vera (PV), or essential thrombocythemia (ET) communities
  • Judging panel reserves the right to exclude nominations of individuals for any perceived conflict of interest
  • Individuals or organizations may not be recognized two years in a row or for a length of time agreed upon by the judging panel. Click here to view past Heroes

2021 Judging Panel

An independent judging panel reviews the nominations and selects the recipients for recognition. The committee is made up of:

Image of Michelle Couri, MD, FACOG, ABIHM

Michele Couri MD, FACOG, ABIHM

Dr. Michele Couri completed her MD at the University of Illinois College of Medicine. She completed her residency in Obstetrics and Gynecology at OSF Saint Francis Medical Center in Peoria, Illinois. She completed a Fellowship in Integrative Medicine through the University of Arizona. She is a Clinical Associate Professor at the University of Illinois College of Medicine in Peoria and is in private practice specializing in Gynecological health, minimally invasive Gynecologic surgery, wellness, and lifestyle medicine. She and her husband Tim are the proud parents of six children.

Dr. Couri is very familiar with MPNs as she was diagnosed with PV in 2010 that progressed to MF in 2020. She underwent a successful stem cell transplant in November 2020. She is the Founder and President of MPN Peoria, a non-profit 501(c)(3) organization whose mission is to raise awareness and funding for MPNs. MPN Peoria was launched in February 2019. To date, MPN Peoria has raised over $200,000 for MPN research. Dr. Couri received the 2020 MPN Heroes award and is humbled to share this honor with all the prior recipients.

Image of Angela Fleischman, MD, PhD

Angela Fleischman MD, PhD

Dr. Angela Fleischman is a physician-scientist investigating hematologic malignancies. She integrates her research with the clinical care of patients with these diseases.

Fleischman's longstanding interest in blood cell development began during her PhD graduate studies at Stanford. After completing her MD and PhD at Stanford, in 2005 she moved to Oregon Health & Science University (OHSU) for her internal medicine residency and medical oncology fellowship.

She joined the University of California, Irvine in July 2013 to develop her independent laboratory group focusing on the pathogenesis of myeloproliferative neoplasms (MPNs). Her laboratory focuses on the role of inflammation in MPNs. Her overarching research goal is to identify what drives disease initiation in MPNs and to ultimately translate her scientific discoveries into therapeutic benefits for MPN patients.

Image of Madeleine Henriquez, PA-C

Madeleine Henriquez PA-C

Madeleine Henriquez is a physician assistant (PA) who graduated from the University of Texas – Medical Branch in Galveston, Texas. Shortly after graduation, she joined the Leukemia Department at the University of Texas MD Anderson Cancer Center where she has worked collaboratively with Dr. Prithviraj Bose to care for MPN patients. Over the past 6 years, she has developed a passion and enthusiasm for this unique patient population. She has thoroughly enjoyed fostering strong, long-lasting relationships with her patients and their caregivers.

Madeleine believes that patient education is the foundation for quality care and positive clinical outcomes. Her goal is to empower her patients to “take charge” of their diagnosis. In addition, she feels that mental health and physical well-being are strongly intertwined, so she promotes this amongst her patients and peers! Madeleine gives many lectures on a local and national level regarding myeloid malignancies with a focus on MPNs. She has partnered with various national media outlets such as MPN Updates through JADPRO to discuss the importance of mental health in patients with MPNs.

In her spare time, Madeleine enjoys spending time with her family. Her hobbies include cooking (her newest venture is toddler-friendly meals), running, mothering her plants, crocheting and trying all the delicious restaurants that Houston has to offer.

Image of Rami S. Komrokji, MD

Rami S. Komrokji MD

Rami S. Komrokji, MD, is a clinical investigator at H. Lee Moffitt Cancer Center. His research focus is on phase I and II clinical trials in Myelodysplastic syndromes (MDS) and acute myeloid leukemia. He is the lead clinical investigator for the MDS Program at the Cancer Center. He has conducted several translational clinical trials working with the program’s basic scientists. He has also developed the MDS database, which is one of the largest is the world. Finally, he serves as the Moffitt Cancer Center PI for the MDS Clinical Consortium, which is an agreement between 6 of the largest MDS Programs in the country for conducting clinical trials in MDS. He serves as a member on the MDS NCCN committee and on the NIH MDS natural history study committee. His work in the field of MDS, specifically conducting clinical trials and outcome research, is well recognized internationally and he has collaborated with all the major MDS programs worldwide.

Image of Nick Napolitano

Nick Napolitano

Nick Napolitano, originally from Staten Island New York, is a Regional Tax Marketing Leader for PwC in New York. He is also the Staten Island Community Committee Chair for the 2021 Light The Night campaign. Nick was diagnosed with Polycythemia Vera (PV) in 2016. The diagnosis, although initially very tough for Nick and his family, is now viewed by Nick as a great gift as it has allowed him to find his true calling as a patient advocate.

Since his diagnosis, he has dedicated himself to educating others and raising awareness of MPNs. Nick has shared his story through a documentary titled “The Unknown.” In it, he discusses his determination to help others meet the challenges of living with an MPN. Nick also partnered with advocacy groups to create and share coronavirus coping strategies for patients with MPNs. He has appeared in numerous webinars and virtual meetings, often discussing topical issues with pioneers in the MPN field. He has been working with LLS for the past 3 years and was a featured patient hero at the 2020 Leukemia & Lymphoma Society’s Light the Night event. He was also recently honored for his advocacy work by CURE Magazine, by being named a 2020 MPN Hero.

Nick knows how important it is to raise awareness and continue to have a drive towards research and funding for all blood cancer patients worldwide. He credits his strong family support and the invaluable and selfless work of advocacy organizations for having a positive influence on his journey with PV. Nick is an avid sports fan and in his spare time coaches his sons' baseball teams. He currently resides in Westchester County with his wife Kara and two sons Nicholas and Jake.


Connect One-on-One With Members of the MPN Community

Register for CHAMPN Connections